Literature DB >> 14593739

Survivin in apoptosis control and cell cycle regulation in cancer.

Dario C Altieri1.   

Abstract

Evasion of apoptosis, and the ability to proliferate uncontrollably are two of the molecular traits found perhaps in all human cancers (1). Positioned at the interface between the regulation of apoptosis and the control of cell proliferation, survivin is a recently described molecule that is expressed in most human cancers but not in normal tissues. Encouraging new studies demonstrate that it may be possible to exploit the survivin pathway for cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593739

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  47 in total

1.  Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Authors:  Qiuying Cheng; Xiang Ling; Andrew Haller; Takahito Nakahara; Kentaro Yamanaka; Aya Kita; Hiroshi Koutoku; Masahiro Takeuchi; Michael G Brattain; Fengzhi Li
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Expressions of survivin and vascular endothelial growth factor in a Murine model of proliferative retinopathy.

Authors:  Na Cai; Ning-Ning Liu; Ning Zhao; Chao Wan; Yue-Dong Hu; Yun Zhou; Lei Chen
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 3.  Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors:  Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

4.  The apoptosis inhibitor survivin prevents insect midgut from cell death during postembryonic development.

Authors:  Hong-Juan He; Li Hou; Jin-Xing Wang; Xiao-Fan Zhao
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

5.  Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain.

Authors:  Ruhi Dixit; Mohd Raza; Mohan Kumar; S Basu; V K Shukla
Journal:  J Gastrointest Cancer       Date:  2018-12

Review 6.  Survivin as a novel target protein for reducing the proliferation of cancer cells.

Authors:  Dongyu Li; Chenghao Hu; Huibin Li
Journal:  Biomed Rep       Date:  2018-03-13

7.  Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?

Authors:  Jaya Nigam; Abhijit Chandra; Hasan Raza Kazmi; Devendra Parmar; Devendra Singh; Vishal Gupta; Noushif M
Journal:  Tumour Biol       Date:  2014-06-17

8.  Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.

Authors:  Gunjan Gakhar; Duy H Hua; Thu Annelise Nguyen
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

9.  Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.

Authors:  Xiang Ling; Diane Calinski; Asher A Chanan-Khan; Muxiang Zhou; Fengzhi Li
Journal:  J Exp Clin Cancer Res       Date:  2010-01-22

10.  Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

Authors:  Claudia Augello; Luca Caruso; Marco Maggioni; Matteo Donadon; Marco Montorsi; Roberto Santambrogio; Guido Torzilli; Valentina Vaira; Caterina Pellegrini; Massimo Roncalli; Guido Coggi; Silvano Bosari
Journal:  BMC Cancer       Date:  2009-04-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.